Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells |
Dana-Farber Cancer Institute / Zhaodong Li, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Characterizing Inflammatory Phenotypes Associated with RUNX1 Deficiency |
Dana-Farber Cancer Institute / Waihay Wong, MD/PhD |
RUNX1 Early Career Investigator Grants |
2021 |
Massachusetts |
The Role of DEF and SSU Processome in Neuroblastoma Pathogenesis |
Dana-Farber Cancer Institute / Ting Tao, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Targeted Hyperactivation of PI3K/AKT in B-cell malignancies |
Dana-Farber Cancer Institute / Vishal Khairnar, PhD |
Young Investigator Grants |
2019 |
Massachusetts |
Therapeutically Targeting a Tumor Suppressor Complex in Aggressive Pediatric Cancers |
Dana-Farber Cancer Institute / Charles Roberts, MD, PhD |
Innovation Grants |
2013 |
Massachusetts |
Development of a Screening Module to Assess Sibling-Related Psychosocial Risk in Families of Children with Cancer |
Boston University / Kristin Long, PhD |
Psychosocial Grants |
2014 |
Massachusetts |
Identification of FDA approved drugs with anti-tumor activity in rhabdomyosarcoma.
|
Massachusetts General Hospital / David Langenau |
Young Investigator Grants |
2009 |
Massachusetts |
SWI/SNF Complex and Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute / Jennifer Wu |
Young Investigator Grants |
2012 |
Massachusetts |
The Therapy-Related Symptom Checklist for Children (TRSC-C): Systematic Monitoring of Symptoms to Improve Oncology Interventions.
|
Kansas Medical Center Research Institute, Inc. / Phoebe Williams |
Nurse Researcher Grants |
2008 |
Kansas |
DNA Sequencing Using Malaria Slides |
Indiana University / Terry Vik, MD |
Epidemiology Grants |
2015 |
Indiana |